• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Poll: What Is Your Prediction for 2021?

Article

The year 2021 could bring momentous developments in the biosimilar field.

Which do you think is most likely to occur in 2021?

The Supreme Court strikes down the whole Affordable Care Act and its biosimilar approval pathway.
The FDA approves the first insulin biosimilar.
Innovator companies launch lower-cost "authorized biologics" in response to biosimilar competition.
The FDA approves the first interchangeable biosimilar.

See what our Advisory Board had to say about 2020 and 2021 in biosimilars.

Recent Videos
Here are the top 5 biosimilar articles for the week of April 14, 2025.
Elena Wolff-Holz, MD
Here are the top 5 biosimilar articles for the week of April 7, 2025.
Here are the top 5 biosimilar articles for the week of March 31, 2025.
Here are the top 5 biosimilar articles for the week of March 24, 2025.
Here are the top 5 biosimilar articles for the week of March 17, 2025.
Here are the top 5 biosimilar articles for the week of March 10, 2025.
Here are the top 5 biosimilar articles for the week of March 3, 2025.
Here are the top 5 biosimilar articles for the week of February 24, 2025.
Here are the top 5 biosimilar articles for the week of February 17, 2025.
Related Content
© 2025 MJH Life Sciences

All rights reserved.